DJO Surgical AltiVate Reverse
Device
ENCORE MEDICAL, LP
Total Payments
$26.7M
Transactions
5,796
Doctors
930
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $6.2M | 857 | 192 |
| 2020 | $5.7M | 627 | 175 |
| 2019 | $6.6M | 1,488 | 312 |
| 2018 | $4.0M | 1,231 | 308 |
| 2017 | $4.2M | 1,593 | 439 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $21.4M | 153 | 80.3% |
| Consulting Fee | $3.8M | 757 | 14.3% |
| Travel and Lodging | $548,410 | 1,681 | 2.1% |
| Unspecified | $451,913 | 95 | 1.7% |
| Honoraria | $220,706 | 93 | 0.8% |
| Food and Beverage | $172,773 | 3,014 | 0.6% |
| Space rental or facility fees (teaching hospital only) | $29,482 | 1 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $791.16 | 2 | 0.0% |
Payments by Type
General
$26.2M
5,701 transactions
Research
$451,913
95 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Entezari DJO-20-006A | ENCORE MEDICAL, LP | $70,427 | 0 |
| Clinical Outcomes of DJO Altivate Reverse Total Shoulder ArthroplastyRSA | ENCORE MEDICAL, LP | $46,250 | 0 |
| Jawa DJO-17-102 | ENCORE MEDICAL, LP | $39,500 | 0 |
| Predictors of Patient Outcome After Revision to Reverse Shoulder Arthroplasty of a Failed Hemiarthroplasty | ENCORE MEDICAL, LP | $35,907 | 0 |
| FRANKLE-DJO-20-009A | ENCORE MEDICAL, LP | $29,439 | 0 |
| Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty A randomized, controlled trial | ENCORE MEDICAL, LP | $28,833 | 1 |
| Evaluation of Proximal Humeral Bone Loss in Revision Surgery for Failed Hemiarthroplasty | ENCORE MEDICAL, LP | $28,800 | 0 |
| FRANKLE-DJO-20-007A | ENCORE MEDICAL, LP | $26,268 | 0 |
| Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty: A randomized, controlled trial | ENCORE MEDICAL, LP | $19,926 | 1 |
| Mid- and Long- Term Outcomes of Reverse Shoulder Arthgroplasty, Hemiarthroplasty, and ORIF in Proximal Humerus Fractures | ENCORE MEDICAL, LP | $18,107 | 0 |
| Siverhus DJO-16-101 | ENCORE MEDICAL, LP | $14,883 | 0 |
| Clinical Outcomes and Function in Patients Treated with Shoulder Arthroplasty Using the AltiVate Anatomic Shoulder System | ENCORE MEDICAL, LP | $12,350 | 0 |
| Frankle DJO-17-107 | ENCORE MEDICAL, LP | $11,000 | 0 |
| Kwon DJO-15-901 | ENCORE MEDICAL, LP | $8,850 | 0 |
| PS-901 DAN RSP | ENCORE MEDICAL, LP | $8,039 | 0 |
| PS-901-FTL RSP | ENCORE MEDICAL, LP | $7,435 | 1 |
| Effect of Reverse Total Shoulder Arthroplasty Baseplate Design on Insertion Torque and Compression Strength Relationship | ENCORE MEDICAL, LP | $6,186 | 0 |
| Hasan PS-901 CIN | ENCORE MEDICAL, LP | $6,180 | 1 |
| PS-901-LOU | ENCORE MEDICAL, LP | $6,125 | 1 |
| A Prospective multicenter study to examine the influence of repairing the sub-scapularis on outcomes after reverse arthroplasty: A randomized, controlled trial. | ENCORE MEDICAL, LP | $5,620 | 0 |
Top Doctors Receiving Payments for DJO Surgical AltiVate Reverse
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Orthopaedic Surgery | Temple Terrace, FL | $11.5M | 213 |
| , MD | Orthopaedic Surgery | Eagle, ID | $4.9M | 61 |
| , M.D | Orthopaedic Surgery | Danville, PA | $1.9M | 193 |
| , M.D | Orthopaedic Surgery | Oakland Park, FL | $1.7M | 187 |
| , MD | Orthopaedic Surgery | La Mesa, CA | $1.5M | 87 |
| , M.D | Sports Medicine | Rancho Mirage, CA | $561,259 | 51 |
| , MD | Orthopaedic Surgery | Philadelphia, PA | $560,578 | 79 |
| , M.D | Hand Surgery | Asheville, NC | $470,293 | 34 |
| Unknown | — | Aurora, CO | $453,254 | 82 |
| , MD | Orthopaedic Surgery | Cleveland, OH | $330,202 | 141 |
| , M.D | Orthopaedic Surgery | Houston, TX | $288,717 | 171 |
| , MD | Orthopaedic Surgery | Avon, IN | $145,919 | 65 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Philadelphia, PA | $131,503 | 133 |
| , M.D., PH.D | Sports Medicine | Cincinnati, OH | $122,902 | 78 |
| , MD | Orthopaedic Surgery | Philadelphia, PA | $116,075 | 57 |
| , M.D | Sports Medicine | Durham, NC | $91,914 | 53 |
| , M.D., PH.D | Orthopaedic Surgery | New York, NY | $76,974 | 26 |
| , MD | Orthopaedic Surgery | Henrico, VA | $64,741 | 40 |
| , MD | Orthopaedic Surgery | Waltham, MA | $61,656 | 31 |
| , M.D | Orthopaedic Surgery | Bangor, ME | $60,802 | 3 |
| , M.D | Orthopaedic Surgery | Venice, FL | $58,043 | 41 |
| , M.D | Orthopaedic Surgery | Saint Louis, MO | $55,950 | 80 |
| , M.D | Sports Medicine | Providence, RI | $52,128 | 44 |
| , MD | Orthopaedic Surgery | Temple Terrace, FL | $48,375 | 43 |
| , M.D | Student in an Organized Health Care Education/Training Program | Aurora, CO | $46,964 | 49 |
Ad
Manufacturing Companies
- ENCORE MEDICAL, LP $26.7M
- DJO, LLC $2,428
Product Information
- Type Device
- Total Payments $26.7M
- Total Doctors 930
- Transactions 5,796
About DJO Surgical AltiVate Reverse
DJO Surgical AltiVate Reverse is a device associated with $26.7M in payments to 930 healthcare providers, recorded across 5,796 transactions in the CMS Open Payments database. The primary manufacturer is ENCORE MEDICAL, LP.
Payment data is available from 2017 to 2021. In 2021, $6.2M was paid across 857 transactions to 192 doctors.
The most common payment nature for DJO Surgical AltiVate Reverse is "Royalty or License" ($21.4M, 80.3% of total).
DJO Surgical AltiVate Reverse is associated with 20 research studies, including "Entezari DJO-20-006A" ($70,427).